{
  "id": "CVE-2017-17678",
  "assigner": "cve@mitre.org",
  "Published": "2021-05-19T12:15:07.367Z",
  "Modified": "2021-06-01T15:14:49.15Z",
  "last-modified": "2021-06-01T15:14:49.15Z",
  "summary": "BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.",
  "access": {
    "authentication": "NONE",
    "complexity": "MEDIUM",
    "vector": "NETWORK"
  },
  "impact": {
    "availability": "NONE",
    "confidentiality": "NONE",
    "integrity": "PARTIAL"
  },
  "cvss": 4.3,
  "exploitabilityScore": 8.6,
  "impactScore": 2.9,
  "cvss-vector": "AV:N/AC:M/Au:N/C:N/I:P/A:N",
  "references": [
    "http://bmc.com",
    "http://remedy.com",
    "https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html",
    "https://seclists.org/fulldisclosure/2017/Oct/52"
  ],
  "vulnerable_configuration": [],
  "vulnerable_product": [],
  "vendors": [],
  "products": [],
  "vulnerable_product_stems": [],
  "vulnerable_configuration_stems": [],
  "cwe": "CWE-79",
  "vulnerable_configuration_cpe_2_2": []
}